Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis.
Saved in:
| Title: | Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis. |
|---|---|
| Authors: | Kian W; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Zemel M; Medical School for International Health, Ben-Gurion University of the Negev., Elobra F; Dermatology Department Soroka Medical Center & Ben-Gurion University., Sharb AA; Internal Medicine Ward, Soroka Medical Center & Ben-Gurion University., Levitas D; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Assabag Y; Internal Medicine Ward, Soroka Medical Center & Ben-Gurion University., Alguayn F; Faculty of Health Sciences, Ben-Gurion University of the Negev., Yakobson A; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Rouvinov K; The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center and Ben-Gurion University., Fuchs L; Medical Intensive care Unit, Soroka University Medical Center, Beer-Sheva, Israel. |
| Source: | Anti-cancer drugs [Anticancer Drugs] 2022 Jan 01; Vol. 33 (1), pp. e738-e740. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
